You are here

Global

Oral antiviral simnotrelvir shows promise for treating mild COVID-19 --study

 

..in the New England Journal of Medicine Chinese researchers have published positive trial results of simnotrelvir, an oral antiviral that can shorten the duration of mild to moderate COVID-19 symptoms.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

First malaria vaccine program for children starts in Cameroon

 

Cameroon will be the first country to routinely give children a new malaria vaccine as the shots are rolled out in Africa.

The campaign due to start Monday was described by officials as a milestone in the decades-long effort to curb the mosquito-spread disease on the continent, which accounts for 95% of the world’s malaria deaths.

...

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

New British study on How Long Does It Take to Get COVID-19

The length of time you spend around a person with COVID-19 seems to heavily influence your likelihood of getting sick, according to a recent Nature study that has been peer-reviewed but not fully edited. Most exposures that result in transmission last at least an hour, if not much longer, the researchers say.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Global
howdy folks